chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tachycardia; This spontaneous case was reported by a patient and describes the occurrence of TACHYCARDIA (tachycardia) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 010M20A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced TACHYCARDIA (tachycardia). At the time of the report, TACHYCARDIA (tachycardia) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 125 breaths per minute and 190 breaths per minute.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  After having the first round of vaccines, within 3-4 weeks of the second shot, patient started having weird heartrate spikes. These started one month after his first round of COVID-19 vaccines. He was a runner and regularly monitors his heart rate. He spoke to his doctor who referred him to a cardiologist. The cardiologist was also able to observe tachycardia. He was not being bothered by this condition anymore. He had seen spikevax labelling information and realized there is a listed risk to discuss an elevated heart rate with his HCP. He had received COVID-19 vaccines as follows: 18MAR2021 (lot number 010M20A) 15APR2021 (lot number 021B21A) 11NOV2021 (lot number 065F21A) 19APR2022 (lot number 005M21A) 23SEP2022 (Pfizer bivalent, lot number GJ8739) His heart rate while running would be 125 BPM then would shoot up to around 190 BPM immediately. Would stop and put down head and that would bring his heart rate down quickly. No pain or dizziness. Just a weird feeling and concerning to him. Last incident was sometime early this past spring. No medications or treatments. Has also received flu shots and shingles vaccine over this time. Shingles was last spring.   treatment information was not provided.
Very tired all day; slight fever (99.3) for a few hours; This is a spontaneous report from a contactable consumer (Patient). A (Age 83; unit Unspecified) non-pregnant female patient received bnt162b2 (COMIRNATY, solution for injection, Batch/Lot Number: FA6780) via an unspecified route of administration, administered in Arm Left on 04Aug2021 11:15 as dose number unknown, single for covid-19 immunisation. Medical history included hypertension from an unknown date. Concomitant medication(s) included atenolol (MANUFACTURER UNKNOWN), chlorthalidone (MANUFACTURER UNKNOWN) taken for an unspecified indication. Other medications in two weeks included multivitamins. No other vaccine was given in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. No known allergies were reported. On 05Aug2021, the patient experienced very tired all day and slight fever (99.3) for a few hours. The patient did not receive any treatment for the events. On 05Aug2021, the patient underwent lab tests and procedures which included body temperature: 99.3. The outcome of the event was recovered on an unspecified date in 2021.  Follow-Up (18Aug2021): Follow-up attempts are completed. No further information is expected.
Information has been received from a 41 year old with no pertinent medical history or drug reactions/allergies who on 01-JUN-2007 was vaccinated with her first dose of Gardasil (lot number unknown) 0.5 mL. There was no concomitant medication used. On 01-JUN-2007 the consumer reported that she experienced nausea following the first dose of Gardasil. The consumer recovered from the nausea on 02-JUN-2007. She did not seek medical attention. No additional information is available.
Individual received a second dose of J&J (1/17/2022) 12 days after she received her first dose of J&J (1/5/2022).  Individual used different last names for both shots but used same address, phone number, date of birth and first name of mother.  She was called and confirmed that she received both shots.
Monday morning 2/12/18, our little patient woke up with cross eyed vision. We immediately called a Pediatric Ophthalmologist and upon reviewing her, requested an emergency MRI at hospital. The thought of our baby going under anesthesia was so terrifying. To see our little baby in the recovery room with an oxygen mask over her face completely passed out because of the anesthesia was a sight no parent EVER wants to see. How could this have happened to our baby? She was perfectly fine on Sunday. We started to put the pieces together and the only conclusion was this could have been a direct cause of her recent MMR vaccine she had last Wednesday. I did notice her acting fussy Saturday, she had serious diarrhea and thought she was catching a cold or possibly teething. Thanks to GOD the MRI results came back normal Thursday. They did see some sinus congestion, but no major mass or tumors. Her ophthalmologist and pediatrician are both saying it?s now a waiting game, this is completely normal and her vision should go back to normal on her own. Worst case, she'll need glasses or surgery. As a mommy, this is NOT normal. When your baby?s eyes are getting worse, there's heavy green mucus in both eyes, you feel like you?re racing against time, you fight, you research, and you're on the phone to get seen by more doctors. This has given me a whole new hunger to know what's in the vaccinations that are given to our children. Again, she was completely normal and her pediatrician even saw her on the day of the vaccine for her 1 year wellness check and said she looked perfectly healthy. I'm a desperate Mama searching for answers and for our baby to get her vision back.
COVID; sick;  Initial information received on 29-Dec-2021 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who was sick and covid while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   In 2000, the patient received an unknown dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number not reported) via unknown route in unknown administration site.  On an unknown date the patient developed non-serious events "sick" (malaise), "covid" (covid-19)  (unknown latency).  Relevant laboratory test results included:  Blood test - On an unknown date:  [have own antibodies and immunity].  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the events (sick, COVID).  At time of reporting, the outcome was Recovered / Resolved on an unknown date for the event sick and was Unknown for the event covid.
Increased menstrual cramping - went from barely any to fairly severe after first injection and has continued after second injection. Still experiencing cramping today while on period.
Petechial rash on his lower extremities; Rash has come and gone with varying intensity over the last several weeks; This spontaneous case was reported by an other health care professional and describes the occurrence of PETECHIAE (Petechial rash on his lower extremities) and RASH (Rash has come and gone with varying intensity over the last several weeks) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PETECHIAE (Petechial rash on his lower extremities) and RASH (Rash has come and gone with varying intensity over the last several weeks). At the time of the report, PETECHIAE (Petechial rash on his lower extremities) and RASH (Rash has come and gone with varying intensity over the last several weeks) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal (normal) normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Patient's age was added, lab data was updated, event outcome was updated.
While  patient was sitting in chair waiting her 15 minute monitoring period in post- immunization waiting area patient fainted. Patient did not fall down or was she injured by fainting. Patient slowly rolled off chair and patients friend helped lower her to floor where patient regained her awareness . Pharmacist raced quickly to be by patient's side to monitor her vitals and to see if an allergic/ anaphylactic reaction had occured. No symptoms of an allergic reaction or anaphylaxis was observed by pharmacist. Patient quickly regained her awareness and stated that fainting is common to her when routine blood work, injections, giving blood, etc.. Patient stated that fainting is something that has occurred several times in her past. No signs of allergic reaction, redness, hives, facial swelling, cardiovascular collapse were observed by pharmacist while closely monitoring her vitals after 911 was called. EMTs and paramedics arrived quickly and after closely examining patient and talking with her it was decided by Paramedics that patient fainted due to an emotional response by patient and there was no allergic reaction or anaphylaxis to report, nor any injury sustained by patient after fainting. Patient was quickly back to normal, and she verbally declined ambulance. Patient stated that she felt fine and that she was going to do some shopping and return home to relax.
HEADACHE; FLU LIKE SYMPTOMS; This spontaneous report received from a patient concerned a 52 year old male. The patient's weight was 170 pounds, and height was 69 inches. The patient's past medical history included cyst, and headache, and concurrent conditions included hypertension, hyperlipidemia, alcoholic, and non-smoker, and other pre-existing medical conditions included the patient had no known allergies, no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A expiry: UNKNOWN) dose was not reported, administered on 06-JUN-2021 for prophylactic vaccination. Concomitant medications included losartan, omeprazole, rosuvastatin calcium, and ubidecarenone.  On 07-JUN-2021, the subject experienced flu like symptoms. On 16-JUN-2021, the subject experienced headache. Treatment medications (dates unspecified) included: ibuprofen, paracetamol, and acetylsalicylic acid/caffeine/paracetamol/salicylamide. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms on 08-JUN-2021, and had not recovered from headache. This report was non-serious.
real dizzy/ woozy; Real weak/ no energy to speak up/ don't have any energy to work; Diarrhea; my legs gave up on bathroom floor for 28 to may be 30 minutes and no energy to get up; I don't feel great; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 69 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: ALEVE. Vaccination history included: Bnt162b2 (dose 1, single), administration date: 10Feb2021, when the patient was 69 years old, for COVID-19 IMMUNISATION, reaction(s): "dizziness". The following information was reported: DIZZINESS (non-serious) with onset 18Mar2021, outcome "not recovered", described as "real dizzy/ woozy"; ASTHENIA (non-serious) with onset 18Mar2021, outcome "unknown", described as "Real weak/ no energy to speak up/ don't have any energy to work"; DIARRHOEA (non-serious) with onset 18Mar2021, outcome "recovered", described as "Diarrhea"; MUSCULAR WEAKNESS (non-serious) with onset 18Mar2021, outcome "unknown", described as "my legs gave up on bathroom floor for 28 to may be 30 minutes and no energy to get up"; MALAISE (non-serious) with onset 18Mar2021, outcome "unknown", described as "I don't feel great". Therapeutic measures were not taken as a result of dizziness, asthenia, diarrhoea, muscular weakness, malaise.  Additional Information: The patient's concomitant therapy included vitamins. The reporter (patient) did not know if the events were from a different problem or if it's common with the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
neurological reaction; This is a spontaneous report from contactable Physician. This physician reported for a consumer (patient).   A male patient of unspecified age received a dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unknown date, as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The caller reported his 32-year-old female wife was hospitalized after a neurological reaction from the first dose of the Pfizer-BioNTech COVID-19 vaccine. He asked if neurological reactions have been reported following the receipt of the COVID-19 vaccine. The caller explained the only similar case he was able to find was regarding an adult male patient who was in his forties or fifties, experienced neurological reaction, after getting a COVID-19 vaccine on an unknown date. The caller stated he has to attend to a patient and could not stay on the line. He explained he won't need a call back if the information was sent to him by email. The caller asked was the second dose of the Pfizer-BioNTech COVID-19 vaccine recommended following a serious adverse reaction from the first dose. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
Patient experience bruising mainly in the left triceps area with spotty bruising in the left bicep area. The bruises are not near the deltoids area but below it. Per patient, the bruising has spread. Recently the bruising extends down to her elbow
Client received first Covid vaccine at approximately  4:30pm.  Client then returned at approximately 4:55pm to another vaccinator and received a 2nd dose the same day.  Client stayed at clinic approximately 35 minutes after 2nd vaccine with no complaints of adverse effects. Mother is aware to call 911/ or take child to ED if adverse reaction occurs.  Mother verbalized understanding.
Pt received chicken pox vaccine about 2 weeks ago and now she has broken out into what mom seems to think is chicken pox.  RN notes: Mom states patient received a Varivax booster on 8/9/10. Now has chicken pox lesions on face, arms, trunk, and knees, first noticed on Monday. Subjective fever and ST this week, temp not taken.
mom of pt states that p/vax pt exp prolonged screaming, crying & restlessness lasting about 3 1/2-4 hrs; mom took pt to pvt MD;
Patient got itchy rash on back, arms and legs (not on face and stomach) starting one week after receiving vaccines. Rash is continuing to get worse. Saw dermatologist who wanted patient to see PCP for follow up regarding kidney function. PCP complete lab work and stated kidney function was normal. Neither felt vaccines were the cause. Patient has appointment with another dermatologist for another evaluation.
Information has been received from a medical assistant referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medication were not reported. On 02-AUG-2016, the patient was vaccinated with a dose of improperly stored RECOMBIVAX HB (dose and route were unknown, lot # L044694, expiration date 04-FEB-2018), which was exposed to temperature excursion of 49 degrees Fahrenheit (F) for 64 hours. There was no previous temperature excursion. Data logger was not involved. No symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
No additional adverse events reported; the patient received an improperly stored dose of ROTATEQ; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, concomitant medications, drug reactions/allergies were not reported.    On 27-APR-2020, the patient received improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 1 dose (strength, route of administration, lot # and expiration date were not provided) as prophylaxis (product storage error). The vaccines were exposed to temperature of 35 degrees Fahrenheit for 8 hours. No previous excursions was reported. The data logger was involved. No additional adverse effects were reported.; Sender's Comments:  US-009507513-2005USA000681: US-009507513-2005USA000643: US-009507513-2005USA000528:
Day 8 post moderna vaccine a very itchy raised rash/hives event, presented.  Day 9 this rash/hives have turned very red and is approximately 3? long by 3?wide. The area is very itchy and tingly with raised areas of rash
Information has been received from a nurse concerning a 23 month old female patient who was vaccinated orally with the three series of ROTATEQ (lot numbers not provided).  The nurse indicated that the patient's parents called physician and reported that the patient had rotavirus in his stool.  As of 15-Jan-2009 the patient status was unknown.  Additional information has been requested.
joint pain in both the left and right hand and both the knees/ aching in knee; muscle pain in both the left and right hand and both the knees; aching in her arms; This case was reported by a other health professional via call center representative and described the occurrence of joint pain in a 52-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 2E3EH, expiry date 31st October 2021) for prophylaxis.   Co-suspect products included HAB (Twinrix adult) (batch number 75C72, expiry date 13th June 2022) for prophylaxis.   On 9th December 2019, the patient received Boostrix (intramuscular). On 11th December 2019, the patient received the 1st dose of Twinrix adult (intramuscular). On 18th December 2019, 9 days after receiving Boostrix and 7 days after receiving Twinrix adult, the patient experienced joint pain, muscle pain and pain in arm. On an unknown date, the outcome of the joint pain, muscle pain and pain in arm were not recovered/not resolved.   It was unknown if the reporter considered the joint pain, muscle pain and pain in arm to be related to Boostrix and Twinrix adult.  Additional details were reported as follows: The patient received a dose of Twinrix Adult and Boostrix on the left deltoid. The patient experienced muscle ache with joint pain in both the left and right hand and both the knees after receiving Boostrix and Twinrix adult vaccines. The aching in her arms and knees was not resolved till the time of reporting. No additional information was provided. The reporter consented to follow up.
Patient received the 1st dose for the Pfizer gray cap series which is for 12 and up. At the time of vaccination patient was 11 years of age. Noticed the error the next day 4/16/23 and tried to contact patient but did not have a correct phone number or physical address. As of right now no adverse events reported.
Rash and itching on injection arm 2 days after and still persisting today 9 days since it began .
Child received Flu vaccine yesterday. Mom says this morning he woke up with his L deltoid area red. Child went to school and starting having mild pain on the arm and the rash got raised and bigger. Denies any respiratory symptoms such as sob, worsening wheezing, swelling of upper airways. 1. Allergic reaction to drug - Local allergic reaction to fLu vaccine (vaccine received 24 hours ago).  Marked area with ink to monitor progression.  Give medicines as prescribed.  May apply cool packs for 15 minutes as needed for comfort.  RTC if rash started to get bigger, child start having respiratory difficulties, worsening of wheezing, sob.   Benadryl Allergy 12.5 mg/5 mL oral liquid - Take 10 mL every 4-6 hours by oral route as needed for 2 days.      ibuprofen 100 mg/5 mL oral suspension - Take 15 mL every 6-8 hours by oral route as needed for 3 days.         PEDIATRIC ALLERGIST REFERRAL
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed the ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 23-JUL-2014, a pharmacist at a pharmacy administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about 09-DEC-2016, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of her injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Telephone interview 10/12/06. Patient reports onset of symptoms began within the hour. Redness and swelling at right arm. Symptoms progressed. Fever greater than 102, nausea, vomiting, dizziness, and arm swelling to twice its size. ER visit; received steroids and Benadryl. On exam 10/13/06, pink area on right arm approximately 6"x4". Not swollen or arm. No open areas noted. Patient reports not feeling 100% without specific complaints. On interview, patient reports fever around 101 and nausea and vomiting and arm swelling.